Original Article | Published:

Stem cell transplantation

Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children

Leukemia volume 31, pages 11451153 (2017) | Download Citation

Subjects

Abstract

αβT-cell-depleted allogeneic hematopoietic cell transplantation holds promise for the safe and accessible therapy of both malignant and non-malignant blood disorders. Here we employed molecular barcoding normalized T-cell receptor (TCR) profiling to quantitatively track T-cell immune reconstitution after TCRαβ-/CD19-depleted transplantation in children. We demonstrate that seemingly early reconstitution of αβT-cell counts 2 months after transplantation is based on only several hundred rapidly expanded clones originating from non-depleted graft cells. In further months, frequency of these hyperexpanded clones declines, and after 1 year the observed T-cell counts and TCRβ diversity are mostly provided by the newly produced T cells. We also demonstrate that high TCRβ diversity at day 60 observed for some of the patients is determined by recipient T cells and intrathymic progenitors that survived conditioning regimen. Our results indicate that further efforts on optimization of TCRαβ-/CD19-depleted transplantation protocols should be directed toward providing more efficient T-cell defense in the first months after transplantation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.

  2. 2.

    , , , , , et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997; 15: 1767–1777.

  3. 3.

    , . The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192–3204.

  4. 4.

    , , , , , et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186–1193.

  5. 5.

    , , , , , et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998; 91: 1083–1090.

  6. 6.

    , , , , , et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93: 467–480.

  7. 7.

    , , , , , et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000; 95: 3996–4003.

  8. 8.

    , , , , , et al. Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1835–1844.

  9. 9.

    , . T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transplant 2014; 49: 999–1008.

  10. 10.

    , , , , , et al. Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy 2013; 15: 1253–1258.

  11. 11.

    , , , , . Negative depletion of alpha/beta+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation. Immunol Lett 2013; 155: 21–23.

  12. 12.

    , , , , , et al. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors. J Immunol Res 2014; 2014: 578741.

  13. 13.

    , , , , , et al. Haploidentical TCR A/B and B-cell depleted hematopoietic SCT in pediatric SAA and aspergillosis. Bone Marrow Transplant 2014; 49: 847–849.

  14. 14.

    , , , , , et al. HLA-haploidentical stem cell transplantation after removal of alphabeta+ T and B cells in children with nonmalignant disorders. Blood 2014; 124: 822–826.

  15. 15.

    , , , , , et al. Single-center experience of unrelated and haploidentical stem cell transplantation with TCRalphabeta and CD19 depletion in children with primary immunodeficiency syndromes. Biol Blood Marrow Transplant 2015; 21: 1955–1962.

  16. 16.

    , , . Thymic T-cell development in allogeneic stem cell transplantation. Blood 2011; 117: 6768–6776.

  17. 17.

    , , , , , et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol 2014; 192: 2689–2698.

  18. 18.

    , , , , , et al. Dynamics of Individual T cell repertoires: from cord blood to centenarians. J Immunol 2016; 196: 5005–5013.

  19. 19.

    , , . Chimerism testing by quantitative PCR using Indel markers. Methods Mol Biol 2013; 1034: 221–237.

  20. 20.

    , , , , , et al. Distinctive properties of identical twins' TCR repertoires revealed by high-throughput sequencing. Proc Natl Acad Sci USA 2014; 111: 5980–5985.

  21. 21.

    , , , , , et al. Towards error-free profiling of immune repertoires. Nat Methods 2014; 11: 653–655.

  22. 22.

    , , , , , et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods 2015; 12: 380–381.

  23. 23.

    , , , , , et al. tcR: an R package for T cell receptor repertoire advanced data analysis. BMC Bioinformatics 2015; 16: 175.

  24. 24.

    , , , , , et al. VDJtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput Biol 2015; 11: e1004503.

  25. 25.

    . R: A Language and Environment for Statistical Computing. R Foundation for statistical computing: Vienna, Austria, 2012.

  26. 26.

    , , , . Counting the uncountable: statistical approaches to estimating microbial diversity. Appl Environ Microbiol 2001; 67: 4399–4406.

  27. 27.

    , , . Sequence analysis of T-cell repertoires in health and disease. Genome Med 2013; 5: 98.

  28. 28.

    , , , , , et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med 2013; 19: 372–377.

  29. 29.

    , , , , , et al. Donor CD4 T cell diversity determines virus reactivation in patients after HLA-matched allogeneic stem cell transplantation. Am J Transplant 2015; 15: 2170–2179.

  30. 30.

    , , , , , et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRbeta repertoire. Blood 2015; 125: 3835–3850.

  31. 31.

    , , , , , et al. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50: 1227–1234.

  32. 32.

    , , , , , et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol Med 2011; 3: 201–207.

  33. 33.

    , , , , , et al. T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J Clin Invest 2014; 124: 1168–1172.

  34. 34.

    , , , , , et al. Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cells. Blood 2015; 127: 91–101.

  35. 35.

    , , , , . Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci USA 2011; 108: 9530–9535.

  36. 36.

    , , , , , et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods 2012; 9: 72–74.

  37. 37.

    , , , , , et al. Quantitative profiling of immune repertoires for minor lymphocyte counts using unique molecular identifiers. J Immunol 2015; 194: 6155–6163.

  38. 38.

    , , , , , et al. A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance. Nature 2015; 528: 132–136.

  39. 39.

    , . Estimating the number of unseen species: How many words did Shakespeare know? Biometrika 1976; 63: 435–447.

  40. 40.

    . A mathematical theory of communication. Bell Syst Tech J 1948; 27: 379–423.

  41. 41.

    . Measurement of diversity. Nature 1949; 163: 688.

  42. 42.

    , , , , , et al. Models and estimators linking individual-based and sample-based rarefaction, extrapolation and comparison of assemblages. J Plant Ecol 2012; 5: 3–21.

  43. 43.

    , , , , . Computational analysis of stochastic heterogeneity in PCR amplification efficiency revealed by single molecule barcoding. Sci Rep 2015; 5: 14629.

  44. 44.

    , , , , , et al. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia. Br J Haematol 2014; 165: 688–698.

  45. 45.

    , , , , , et al. Human peripheral CD4(+) Vdelta1(+) gammadelta T cells can develop into alphabetaT cells. Front Immunol 2014; 5: 645.

  46. 46.

    , , . T cell immune reconstitution following lymphodepletion. Semin Immunol 2007; 19: 318–330.

  47. 47.

    , . Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 2004; 173: 1209–1218.

  48. 48.

    , , . The cell cycle time of CD8+ T cells responding in vivo is controlled by the type of antigenic stimulus. PLoS One 2010; 5: e15423.

  49. 49.

    , , . Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am 2011; 25: 151–169.

  50. 50.

    , , , , , . Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia. Biol Blood Marrow Transplant 2016; 22: 300–306.

  51. 51.

    , , , , , et al. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014; 20: 655–661.

  52. 52.

    , . Renewing the T cell repertoire to arrest autoimmune aggression. Trends Immunol 2006; 27: 61–67.

  53. 53.

    , , , , , et al. First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy. Bone Marrow Transplant 2012; 47: 1479–1481.

  54. 54.

    , , . Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004; 34: 1–12.

  55. 55.

    , , , , , et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32: 1001–1014.

  56. 56.

    , . Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115: 3861–3868.

  57. 57.

    , , , , , et al. Cytomegalovirus infection reduces telomere length of the circulating T cell pool. J Immunol 2010; 184: 3417–3423.

  58. 58.

    , , , , , et al. The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection. Blood 2001; 97: 700–707.

  59. 59.

    , , , , , et al. Rapid salvage treatment with virus-specific T cells for therapy-resistant disease. Clin Infect Dis 2012; 55: 1064–1073.

  60. 60.

    , , , , , et al. Short-term in vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application. PLoS One 2013; 8: e59592.

  61. 61.

    , , . Antiviral T-cell therapy. Immunol Rev 2014; 258: 12–29.

  62. 62.

    , , , , , et al. CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med 2015; 7: 285ra263.

  63. 63.

    , , , , , et al. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts. J Clin Invest 2015; 125: 2677–2689.

  64. 64.

    , , , , , et al. Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies. Bone Marrow Transplant 2015; 50: 968–977.

  65. 65.

    , , , , , . Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability. Pediatr Blood Cancer 2015; 62: 666–673.

  66. 66.

    , , , , , et al. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: a preliminary study. J Allergy Clin Immunol 2015; 135: 1303–1309, e1301-1303.

  67. 67.

    , , , , , . Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 2001; 98: 1847–1851.

Download references

Acknowledgements

The collection and clinical analysis of samples was supported by Russian Science Foundation grant no 14-35-00105. TCR library preparation and sequencing was supported by Russian Science Foundation grant no 15-15-00178. Zvyagin I is supported by grant MK-4583.2015.4. The work was carried out in part using equipment provided by the Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry Core Facility (CKP IBCH). Hematopoietic stem cell transplant program at Dmitriy Rogachev Federal center of pediatric hematology, oncology and immunology is kindly supported by charitable fund ‘Podari Zhizn’. We thank our donors, physicians and nursing staff of the hematopoietic stem cell transplantation department.

Author information

Author notes

    • I V Zvyagin
    • , I Z Mamedov
    • , O V Tatarinova
    •  & E A Komech

    These authors contributed equally to this work.

Affiliations

  1. Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Science, Moscow, Russia

    • I V Zvyagin
    • , I Z Mamedov
    • , E A Komech
    • , M Shugay
    • , A L Sycheva
    • , S A Kasatskaya
    • , Y B Lebedev
    •  & D M Chudakov
  2. CEITEC MU, Masaryk University, Brno, Czech republic

    • I V Zvyagin
    • , I Z Mamedov
    • , M Shugay
    •  & D M Chudakov
  3. Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia

    • O V Tatarinova
    • , E E Kurnikova
    • , E V Boyakova
    • , V Brilliantova
    • , L N Shelikhova
    • , D N Balashov
    • , A A Maschan
    •  & M A Maschan
  4. Pirogov Russian National Research Medical University, Moscow, Russia

    • M Shugay
    • , A A Maschan
    • , M A Maschan
    •  & D M Chudakov

Authors

  1. Search for I V Zvyagin in:

  2. Search for I Z Mamedov in:

  3. Search for O V Tatarinova in:

  4. Search for E A Komech in:

  5. Search for E E Kurnikova in:

  6. Search for E V Boyakova in:

  7. Search for V Brilliantova in:

  8. Search for L N Shelikhova in:

  9. Search for D N Balashov in:

  10. Search for M Shugay in:

  11. Search for A L Sycheva in:

  12. Search for S A Kasatskaya in:

  13. Search for Y B Lebedev in:

  14. Search for A A Maschan in:

  15. Search for M A Maschan in:

  16. Search for D M Chudakov in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to D M Chudakov.

Supplementary information

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/leu.2016.321

Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)

Further reading